Related Experiment Video
Updated: Aug 24, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Wilson's disease: diagnostic errors and clinical implications
L K Prashanth1, A B Taly, S Sinha
1Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Background:
Therapeutic outcome of Wilson's disease (WD) significantly depends upon its early recognition. However, because of its rarity in community and protean manifestations, the diagnosis and treatment are often delayed.
Aim:
To ascertain diagnostic errors at initial evaluation in these patients.
Methods:
Analysis of medical records of 307 patients of WD registered over 30 years was done regarding presenting manifestations, initial diagnostic omissions, and interval between onset of symptoms to diagnosis and treatment.
Results:
Of the 307 patients of WD diagnostic errors by referring doctors from different specialties of health care were detected in 192 patients. These were diverse and multiple and included schizophrenia, juvenile polyarthritis, rheumatic chorea, nephrotic syndrome, metachromatic leucodystrophy, congenital myopathies, subacute sclerosing panencephalitis, neurodegenerative disease among others. The mean (SD) delay was two (three) years (range: 0.08-30 years). Some of the interventions before establishment of correct diagnosis were electroconvulsive therapy, thalamotomy, antipsychotics, and surgical correction for bony deformity. While 98 patients were referred with correct diagnosis, only 16 were given specific treatment.
Conclusion:
Awareness among health professionals about varied presenting features of WD and high index of suspicion may have prognostic implications.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Errors occurring during blood pressure monitoring
Several factors...
Automated Microbial Diagnostics
Nephrotic Syndrome I : Introduction
Therapeutic Drug Monitoring: Affecting Factors
